Streetbeat News

Products Services

LAES

SEALSQ has introduced advanced features for its digital crypto wallet to safeguard against threats from quantum computing. This development is crucial as quantum computing poses potential risks to digital security.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 11:16 am

GRMN

Garmin has announced the Enduro 3, a next-generation ultraperformance GPS smartwatch, which could enhance its product lineup and appeal to fitness enthusiasts.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 11:10 am

GRMN

Garmin has announced the launch of its fēnix 8 series, a new line of premium multisport GPS smartwatches. This product launch could enhance Garmin's market position in the wearable technology sector.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 11:10 am

PMTS

CPI Card Group has partnered with Rippleshot to enhance its fraud detection capabilities using AI-powered solutions. This collaboration aims to improve security measures for CPI Card Group's offerings.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 11:08 am

CLSD

Clearside Biomedical has completed the final participant visit in its ODYSSEY Phase 2b trial for CLS-AX, a treatment for wet age-related macular degeneration (AMD). This milestone is crucial for the company's progress in developing this treatment.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 11:06 am

V

Visa has announced the launch of its Money Movement Advisory Practice in the US and Canada, aiming to enhance its services in the financial sector.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 11:05 am

IVVD

Invivyd's shares rose following the announcement of positive 180-day exploratory clinical efficacy data from the CANOPY Phase 3 trial of Pemivibart, which showed an 84% relative risk reduction in symptomatic COVID-19 compared to placebo.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 11:04 am

LYFT

Lyft and Payfare have introduced new features for the Lyft Direct Debit Card and Banking App, enhancing financial services for Lyft drivers.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 11:03 am

IVVD

Invivyd has announced promising 180-day exploratory clinical efficacy data from its CANOPY Phase 3 trial of Pemivibart, showing an 84% relative risk reduction in symptomatic COVID-19 compared to a placebo.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 11:02 am

AUTL

Autolus Therapeutics (NASDAQ:AUTL) will present data on tumor burden-guided dosing at the SOHO 2024 Annual Meeting. The data focuses on the impact of bone marrow blast percentage in patients with relapsed/refractory B-Cell Acute Lymphoblastic Leukemia treated with obe-cel.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 11:02 am